Modelling the impact of male circumcision on HIV/AIDS in sub-Saharan Africa Brian Williams, SACEMA 14 November 2007.

Slides:



Advertisements
Similar presentations
The Epidemiology of HIV/AIDS in the Republic of Trinidad/Tobago With special reference to Women and Children Robert K. Lee MB,ChB;MPH.
Advertisements

The Sexual Health Needs of Youth in Tobago Paper presented at the Centre for Caribbean Medicine Conference, Centre for Caribbean Medicine Conference, St.
Abortion Worldwide: A Decade of Uneven Progress
Scaling up HIV services for women and children achievements and challenges e-lluminate session e-lluminate session Yves Souteyrand 2 March 2010.
HIV/AIDS Weakens the Immune System
EPIDIOMOLGY OF HIV IN NIGERIA by Dr Ibrahim M Kida.
Asia and Pacific Overview of the HIV Epidemic and Response JVR Prasada Rao Regional Support Team Asia & Pacific Bangkok ICAAP, Kobe, July 2005.
AIDS in Africa: Past and Future Peter Piot Souleymane Mboup Meskerem Grunitzky Bekele.
HIV/AIDS Estimation and Projections: Overview of Methods and Activities.
STIs in Victoria who why prevention Rebecca Guy Centre for Epidemiology and Population Health Research, The Macfarlane Burnet Institute for Medical Research.
TB/HIV Research Priorities in Resource- Limited Settings Where we are now and some suggestions for where to go Paul Nunn February 2005.
No Goals at Half-time: What Next for the Millennium Development Goals? Goal 6: Combating HIV/AIDS, malaria and other diseases John Porter.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the UK – 30 years on… Since 1981: 122,000 HIV diagnoses.
NEO K MOROJELE, PHD CONNIE T KEKWALETSWE, PHD Alcohol and Drug Abuse Research Unit SOUTH AFRICAN MEDICAL RESEARCH COUNCIL The Role of Alcohol Use in the.
Methods for establishing the extent of HIV epidemics and trends in prevalence Geoff Garnett Imperial College London.
Antiretroviral Therapy: An HIV Prevention Strategy? Wafaa El-Sadr, MD, MPH Columbia University Harlem Hospital New York.
Male Circumcision “Jeopardy!” Game
COMMITMENTS MADE AND THE STATE OF THE EPIDEMIC IN YOUNG PEOPLE.
Mark Jit Modelling and Economics Unit Health Protection Agency, London Case study: Structural uncertainty in human papillomavirus vaccination modelling.
Asthma in Minnesota Slide Set Asthma Program Minnesota Department of Health January 2013.
TOWARDS UNIVERSAL ACCESS
Julio Montaner, MD Professor of Medicine, and Head, Div. of AIDS, University of British Columbia Director, BC-Centre for Excellence in HIV/AIDS at Providence.
Treatment as Prevention (TasP)
HYPnet Late presentation of vertically transmitted HIV infection in adolescence A Judd 1, R Ferrand 2,3, E Jungmann 2, C Foster 4, H Lyall 4, Brian Rice.
National Institute for Public Health and the Environment HIV, HCV, and HBV in injecting drug users in Europe Mirjam Kretzschmar Centre for Infectious Disease.
Circumcision Status and HIV Infection among Black and Latino MSM in 3 US Cities Gregorio A Millett Centers for Disease Control Division of HIV/AIDS Prevention.
HIV/AIDS and Women: An Overview Global HIV/AIDS and Women: Current Challenges and Opportunities Briefing, Rayburn House Office Building Jen Kates, PhD.
Sexual networks and HIV infection Partnership concurrency and (some of) its possible implications Stéphane Helleringer PopFam.
Why is HIV Prevalence So Severe in Southern Africa?, and “What Works” (and Doesn’t) for AIDS Prevention? Daniel Halperin, PhD, MS Senior Advisor for Behavior.
HPV-vaccines – a breakthrough in medicine Björn Strander Onkologiskt centrum Västra regionen and Kungsbacka Närsjukhus Sweden.
Feasibility and acceptability of an antiretroviral treatment as prevention (TasP) intervention in rural South Africa Results from the ANRS TasP cluster-randomised.
Women and ARV-based Prevention: Challenges and Opportunities Tim Mastro, MD, DTM&H AIDS 2014 Melbourne, Australia 24 July 2014.
Using longitudinal, population-based HIV surveillance to measure the real-world impacts of ART scale-up in KwaZulu- Natal, South Africa Frank Tanser Presentation.
The PEPFAR Blueprint for an AIDS Free Generation Implications for Uganda’s response to HIV Alice Kayongo-Mutebi, Community Health Alliance Uganda 14 February.
PEPFAR Emmanuel Njeuhmeli, MD, MPH, MBA Senior Biomedical Prevention Advisor and Co-Chair PEPFAR Male Circumcision Technical Working Group Office of HIV/AIDS.
Modelling HIV/AIDS in Southern Africa Centre for Actuarial Research (CARe) A Research Unit of the University of Cape Town.
Attaining Realistic and Substantial Reductions in HIV Incidence: Model Projections of Combining Microbicide and Male Circumcision interventions in Rural.
HIV Modelling & Economics Estimating the potential impact and efficiency of PrEP for FSWs and MSM in Bangalore, southern India K.M. Mitchell 1, H.J. Prudden.
HIV/AIDS Major effects on women and children in developing countries.
How well are we doing in preventing HIV and how can we do better?
Financial Incentives & HIV prevention in Sub-Saharan Africa: Evidence from Three Experimental Interventions Berk Özler & Damien de Walque Development Research.
A random household survey of male circumcision and HIV in Kisumu, Kenya Circumcision Impact Study (CIRCIS) Matthew Westercamp University of Illinois at.
Summarising Male Circumcision Efficacy: Results of the three randomised clinical trials Neil A Martinson Perinatal HIV Research Unit.
Male Circumcision and HIV prevention, the Evidence and potential Impact on HIV incidence in Zimbabwe Karin Hatzold, MD, MPH Director HIV Services PSI Zimbabwe.
Moving from a commodity approach: “Fund some of everything” or “Fund what is comfortable” to An Investment approach: “Fund evidenced-based activities.
Population-based impact of ART in high HIV prevalence settings Marie-Louise Newell Professor of Global Health Faculty of Medicine, Faculty of Social and.
OVERVIEW OF THE HIV/AIDS EPIDEMIC Marie Laga
Cost-effectiveness of male circumcision in reducing the spread of HIV in the general population in sub-Saharan Africa Jim Kahn & Elliot Marseille, UCSF.
Office of Global Health and HIV (OGHH) Office of Overseas Programming & Training Support (OPATS) Session: Voluntary Medical Male Circumcision (VMMC)
Catherine Hankins MD MSc FRCPC Chief Scientific Adviser to UNAIDS Office of the Deputy Executive Director Scaling up male circumcision programmes in Eastern.
Return on investment: How do whole societies benefit from improved services and coverage for key populations? Bradley Mathers Kirby Institute UNSW Australia.
AIDS in Sub Saharan Africa AIDS – a virus with no known cure first identified in the Belgian Congo in It’s now a global epidemic, and poverty and.
Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London.
PEPFAR Cost and Impact of Scaling Up EIMC in Southern and Eastern Africa using the DMPPT 2.0 Model AIDS 2014 – Stepping Up The Pace Emmanuel Njeuhmeli,
FBO Engagement in Male Circumcision May 25, 2009 CCIH Annual Conference.
Assessing Costs and Impact on the Epidemic of Male Circumcision Catherine Hankins UNAIDS 5th IAS Conference on HIV Pathogenesis,
Strategic Information and the Control of Tuberculosis Brian Williams and Chris Dye TB programme, Monitoring and Evaluation, WHO.
© Imperial College LondonPage 1 Understanding the current spread of HIV Geoff Garnett.
Mathematical modelling of male circumcision in sub-Saharan Africa predicts significant reduction in HIV prevalence Greg Londish 1, John Murray 1,2 1 School.
Evaluating the Impact of the Voluntary Medical Male Circumcision Program in Kenya Francis Ndwiga Benson 1, Mathews Onyango 2, John Stover 3 1 National.
1 06/06 e Global HIV epidemic, 1990 ‒ 2005*HIV epidemic in sub-Saharan Africa, 1985 ‒ 2005* Number of people living with HIV % HIV prevalence, adult (15-49)
HIV/AIDS Epidemic in India Trends, Lessons, Challenges & Opportunities
How complicated do we want to make this?
IAEN Conference (20 July 2018)
Male Circumcision & HIV Prevention
Global summary of the AIDS epidemic, December 2007
Global summary of the HIV and AIDS epidemic, 2005
Progress on Voluntary Medical Male Circumcision for HIV prevention and How VMMC fits into UNAIDS ' ' target Julia Samuelson, Nurse epidemiologist.
Trends in the HIV incidence rate following ART scale-up in a rural and hyper-endemic South Africa population (2004–2015) Alain Vandormael, PhD School of.
Global summary of the HIV and AIDS epidemic, 2005
Presentation transcript:

Modelling the impact of male circumcision on HIV/AIDS in sub-Saharan Africa Brian Williams, SACEMA 14 November 2007

The purpose of models is not to fit the data but to sharpen the questions Karlin, S. 11th R.A. Fisher Memorial Lecture, Royal Society, 6 Carlton House Terrace, London. 20 April 1983.

Question 1 Male circumcision reduces female-to-male transmission by 60%; what is the overall population level effect?

Question 2 How many men do we need to circumcise now to avert one future case of infection?

Question 3 How many men do we need to circumcise to avert one future case in a women?

Question 4 At what age should we circumcise men or boys?

Question 5 Over what time scale will we see the effects?

Question 6 How does the age-specific prevalence/incidence of infection vary over time in response to MC?

Question 7 How do sexual mixing patterns affect the impact of MC?

Question 8 Sexual network are almost always scale free. How does this affect the impact of MC?

Question 9 How many (discounted) dollars and lives do we save in the future for each dollar spent now?

Question 10 What kind of synergies might we expect from other interventions?

Summary Overall impact Targeting Impact Time scale Effectiveness Cost benefit

Circumcision reduces incidence in men by = 60% (32% to 76%) Reduces overall incidence (both ways) by * = = 37% (18% to 51%) Equivalent to a one-shot vaccine with life- long protection and an efficacy of 37% Auvert, B. et al., Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk PLOS Medicine, 2005, 2; Bailey, A. et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. The Lancet, : ; Gray, R. et al., Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. The Lancet, :

Change in incidence if all men were circumcised

Greatest benefits to be had where prevalence is high and circumcision rates are low.

Circumcisions to avert one HIV infection Prevalence of HIV (%) Prevalence of male circumcision (%)

Life-time infections averted per circumcision done approximately equal to the prevalence

Impact of male circumcision on HIV in South Africa. Reduction in transmission = 37%. Full coverage by Mortality/yr Prevalence Incidence/yr Over 20 years this could: Avert 1.4M incident cases Reduce prevalence by 1.6M Save 0.8M lives (or people on ART).

The personal benefit is immediate; the full public health benefit will only be seen over ten years or more.

Incidence/year Prevalence Age (years) Williams, B.G. et al. Patterns of infection: using age prevalence data to understand the epidemic of HIV in South Africa. South African Journal of Science, : Williams, B.G. et al. Estimating HIV incidence rates from age prevalence data in epidemic situations. Statistics in Medicine, : Prevalence and incidence (per susceptible person) of HIV among men in Khutsong, South Africa ANC HIV prevalence

Life time risk of infection if susceptible Life time risk of infection (total) Discounted male infections averted per circumcision Risk of infection/Infections averted Age at circumcision (years)

Mean time to infection Discounted male infections averted per circumcision Infections averted Age at circumcision (years) Years

We need to think about the age at circumcision and the time over which the impact will be seen

Heterogeneity in sexual activity? Two kinds of networks Erdos-Renyi or Poisson networks: All partners are equal (but some are more equal than others). Scale free or power-law networks: To him that hath shall be given (and to him that hath not shall be taken away even that which he hath).

No. sexual partners in the last year (Sweden) month (Carletonville) Gilgen, D., et al., The natural history of HIV/AIDS in a major gold-mining centre in South Africa: results of a biomedical and social survey. South African Journal of Science, : Liljeros, F. et al., The web of human sexual contacts. Nature, (6840): Power k = Relative frequency

Change in prevalence by partners and time (years given inset). Power law network cut-off at 30 partners Age at circumcision (years) Prevalence of HIV Number of partners

Transmission parameter Steady state prevalence Circumcise all men Circumcise 5% with 5+ partners Prevalence versus transmission for a power law network. Power = 2.3. Cut-off at 30 red; 5 green; circumcise if more than 5 blue. Remove 5% of men with 5+ partners

Mean no. of sexual partners in last month Age at circumcision (years) Mean number of partners Age (years) Men Women Gilgen, D., et al., The natural history of HIV/AIDS in a major gold-mining centre in South Africa: results of a biomedical and social survey. South African Journal of Science, :

Start with men aged 25 to 35

Summary MC reduces overall transmission by ~40%. Greatest benefit where prevalence is high, circumcision is low and populations are large. Infections averted per circumcision approximately equal to the prevalence. Personal benefit is immediate; the public health benefit takes much longer. Circumcise young men, then middle aged men then children. Find ways to target high risk men.